What is the catalog number for NMDAR2A/GRIN2A Rabbit Polyclonal Antibody?

The catalog number for NMDAR2A/GRIN2A Rabbit Polyclonal Antibody is orb251518.

What sizes are available for NMDAR2A/GRIN2A Rabbit Polyclonal Antibody?

NMDAR2A/GRIN2A Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is NMDAR2A/GRIN2A Rabbit Polyclonal Antibody in stock?

NMDAR2A/GRIN2A Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

NMDAR2A/GRIN2A Rabbit Polyclonal Antibody

Anti-NMDAR2A/GRIN2A Antibody. Tested in WB applications. This antibody reacts with Human, Mouse, Rat.

Product Specifications

Product Name Alternative

Glutamate receptor ionotropic, NMDA 2A; GluN2A; Glutamate [NMDA] receptor subunit epsilon-1; N-methyl D-aspartate receptor subtype 2A; NMDAR2A; NR2A; hNR2A; GRIN2A; NMDAR2A

UniProt

Q12879

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human NMDAR2A recombinant protein (Position: D958-R1300) . Human NMDAR2A shares 89% and 90% amino acid (aa) sequence identity with mouse and rat NMDAR2A, respectively.

Target

Glutamate receptor ionotropic, NMDA 2A

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Neuroscience

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Mouse, Rat, Human

Form

Lyophilized

Molecular Weight

165 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.